The scales for leukemia patients according to the sensitivity of tumor cells to chemotherapeutics, therapy response, MDR1 mRNA and P-gp levels, and the presence of unfavorable immunological and genetic markers were designed for subsequent correlation analysis. This evidence concerns the gene PGP and neoplasm.